Apolipoprotein C-III
- 24 May 2013
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 112 (11), 1405-1408
- https://doi.org/10.1161/circresaha.113.301464
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- HypertriglyceridemiaNutrients, 2013
- Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins: EVIDENCE THAT ApoC-III PLAYS A MAJOR ROLE IN THE FORMATION OF LIPID PRECURSORS WITHIN THE MICROSOMAL LUMEN*Published by Elsevier BV ,2011
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementEuropean Heart Journal, 2011
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein PhenotypeCirculation, 2010
- Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJama-Journal Of The American Medical Association, 2009
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent CardioprotectionScience, 2008
- Association between the -455T>C promoter polymorphism of the APOC3gene and the metabolic syndrome in a multi-ethnic sampleBMC Medical Genetics, 2007
- APOC3 Promoter Polymorphisms C-482T and T-455C Are Associated with the Metabolic SyndromeArchives of Medical Research, 2007